Search Results | Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Abstract 1202: Tumor cell intrinsic STING signaling demonstrates minimal contribution to the anti-tumor response elicited by the STING agonist ADU-S100 (MIW815)

Leticia Corrales, Antony L. Desbien, Kelsey E. Sivick Gauthier, Weiwen Deng, Tamara Schroeder, Gabrielle L. Reiner, Natalie Surh, Brian Francica, Ken Metchette, Chudi O. Ndubaku, Jeffrey M. McKenna, Yan Feng, Lianxing Zheng, Steven L. Bender, Charles Y. Cho, Andrea van Elsas, Meredith L. Leong, Sarah M. McWhirter

Cancer Res (2019) 79 (13_Supplement): 1202.

DOI: https://doi.org/10.1158/1538-7445.AM2019-1202

Published: 01 July 2019

View article

Journal Articles

Abstract 631: Intratumoral activation of STING with a synthetic cyclic dinucleotide elicits antitumor CD8 T-cell immunity that effectively combines with checkpoint inhibitors

Cancer Res (2018) 78 (13_Supplement): 631.

DOI: https://doi.org/10.1158/1538-7445.AM2018-631

Published: 01 July 2018

View article

Journal Articles

Abstract 1445: STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity

Cancer Res (2016) 76 (14_Supplement): 1445.

DOI: https://doi.org/10.1158/1538-7445.AM2016-1445

Published: 15 July 2016

View article

Journal Articles

Abstract SY39-02: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity

Cancer Res (2016) 76 (14_Supplement): SY39-02.

DOI: https://doi.org/10.1158/1538-7445.AM2016-SY39-02

Published: 15 July 2016

View article

Journal Articles

Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity

Gang Li, Lianglin Zhang, Enhong Chen, Jianying Wang, Xin Jiang, Jeffrey H. Chen, Grant Wickman, Karin Amundson, Simon Bergqvist, James Zobel, Dana Buckman, Sangita M. Baxi, Steven L. Bender, Gerald F. Casperson, Dana D. Hu-Lowe

Cancer Res (2010) 70 (24): 10243–10254.

DOI: https://doi.org/10.1158/0008-5472.CAN-10-1996

Published: 14 December 2010

View article

Includes: Supplementary data

Journal Articles

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

Helen Y. Zou, Qiuhua Li, Joseph H. Lee, Maria E. Arango, Scott R. McDonnell, Shinji Yamazaki, Tatiana B. Koudriakova, Gordon Alton, Jingrong J. Cui, Pei-Pei Kung, Mitchell D. Nambu, Gerrit Los, Steven L. Bender, Barbara Mroczkowski, James G. Christensen

Cancer Res (2007) 67 (9): 4408–4417.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-4443

Published: 04 May 2007

View article

Includes: Supplementary data

NARROW

Abstract 1202: Tumor cell intrinsic STING signaling demonstrates minimal contribution to the anti-tumor response elicited by the STING agonist ADU-S100 (MIW815)

Abstract 631: Intratumoral activation of STING with a synthetic cyclic dinucleotide elicits antitumor CD8 T-cell immunity that effectively combines with checkpoint inhibitors

Abstract 1445: STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity

Abstract SY39-02: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity

Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

Email alerts

AACR Journals

Abstract 1202: Tumor cell intrinsic STING signaling demonstrates minimal contribution to the anti-tumor response elicited by the STING agonist ADU-S100 (MIW815)

Abstract 631: Intratumoral activation of STING with a synthetic cyclic dinucleotide elicits antitumor CD8 T-cell immunity that effectively combines with checkpoint inhibitors

Abstract 1445: STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity

Abstract SY39-02: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity

Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only